MMCM
SBRA icon

Murphy & Mullick Capital Management’s Sabra Healthcare REIT SBRA Stock Holding History

Murphy & Mullick Capital Management’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.6K Buy
2,030
+15
+0.7% +$298 0.02% 334
2026
Q1 		$38.8K Buy
2,015
+7
+0.3% +$138 0.03% 315
2025
Q4 		$38K Buy
2,008
+1,008
+101% +$18.7K 0.03% 331
2025
Q3 		$17.5K Hold
1,000
– – 0.01% 407
2025
Q2 		$18.4K Hold
1,000
– – 0.02% 382
2025
Q1 		$17.5K Hold
1,000
– – 0.02% 379
2024
Q4 		$17.3K Buy
+1,000
New +$18.3K 0.02% 373

Other funds holding SBRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIM
Centersquare Investment Management Conshohocken, Pennsylvania $11.7B AUM 20.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Murphy & Mullick Capital Management's SBRA Position: Q2 2026 in Review

Murphy & Mullick Capital Management increased its Sabra Healthcare REIT (SBRA) stake by 0.74% in Q2 2026, buying an estimated $298 and bringing the position to 2,030 shares worth $39.6K. The position accounts for 0.02% of the portfolio, ranked #334.

Murphy & Mullick Capital Management first reported a position in SBRA in Q4 2024 and has held it in 7 quarters since. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Murphy & Mullick Capital Management held 2,030 shares of Sabra Healthcare REIT worth $39.6K as of Q2 2026.
  • Murphy & Mullick Capital Management bought 15 Sabra Healthcare REIT shares in Q2 2026, an estimated $298.
  • Sabra Healthcare REIT made up 0.02% of Murphy & Mullick Capital Management's portfolio in Q2 2026, its #334 holding.
  • Murphy & Mullick Capital Management first reported a position in Sabra Healthcare REIT in Q4 2024 and has held it in 7 quarters since.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.